Sterling Capital Management LLC Intra Cellular Therapies, Inc. Call Options Transaction History
Sterling Capital Management LLC
- $7.74 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ITCI
# of Institutions
377Shares Held
85MCall Options Held
299KPut Options Held
130K-
Vanguard Group Inc Valley Forge, PA9.63MShares$849 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$558 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY5.29MShares$466 Million0.03% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.85MShares$340 Million1.4% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.05MShares$269 Million3.36% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $8.33B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...